Emery P - Search Results

1

Efficacy and safety of leflunomide and predisposing factors for treatment response in patients with active rheumatoid arthritis: RELIEF 6-month data.

Dougados M, Emery P, Lemmel EM, de la Serna R, Zerbini CA, Brin S, van Riel P. Dougados M, et al. Among authors: emery p. J Rheumatol. 2003 Dec;30(12):2572-9. J Rheumatol. 2003. PMID: 14719196 Clinical Trial.

2

Nabumetone compared with naproxen in the treatment of rheumatoid arthritis: a multicenter, double blind, randomized, parallel group trial in hospital outpatients.

Emery P, Clarke A, Williams P, Kill D, Cree F, Redhead R, Poland M. Emery P, et al. J Rheumatol Suppl. 1992 Nov;36:41-7. J Rheumatol Suppl. 1992. PMID: 1474534 Clinical Trial.

3

Activity of rheumatoid arthritis and levels of collagen antibodies: a prospective study.

Stockman A, Rowley MJ, Emery P, Muirden KD. Stockman A, et al. Among authors: emery p. Rheumatol Int. 1989;8(6):239-43. doi: 10.1007/BF00270978. Rheumatol Int. 1989. PMID: 2727549

4

Therapeutic approaches for early rheumatoid arthritis. How early? How aggressive?

Emery P. Emery P. Br J Rheumatol. 1995 Nov;34 Suppl 2:87-90. Br J Rheumatol. 1995. PMID: 8535655 Review.

5

The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome.

Devlin J, Gough A, Huissoon A, Perkins P, Holder R, Reece R, Arthur V, Emery P. Devlin J, et al. Among authors: emery p. J Rheumatol. 1997 Jan;24(1):9-13. J Rheumatol. 1997. PMID: 9002004

6

Safety and tolerability of conversion from stable Sandimmun maintenance treatment to Sandimmun Neoral in patients with rheumatoid arthritis.

Flipo RM, Emery P, Scott DG, Situnayake RD, Prowse PJ, James DW, Cawley MI, Whatmough I, Schmidt AG. Flipo RM, et al. Among authors: emery p. J Rheumatol. 1998 Jul;25(7):1263-9. J Rheumatol. 1998. PMID: 9676754 Clinical Trial.

7

Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors.

Pease CT, Bhakta BB, Devlin J, Emery P. Pease CT, et al. Among authors: emery p. Rheumatology (Oxford). 1999 Mar;38(3):228-34. doi: 10.1093/rheumatology/38.3.228. Rheumatology (Oxford). 1999. PMID: 10325661

8

Disease modification in rheumatoid arthritis with leflunomide.

Emery P. Emery P. Scand J Rheumatol Suppl. 1999;112:9-14. doi: 10.1080/030097499750042236. Scand J Rheumatol Suppl. 1999. PMID: 10668522 Clinical Trial.

9

Microemulsion formulation of cyclosporin (Sandimmun Neoral) vs Sandimmun: comparative safety, tolerability and efficacy in severe active rheumatoid arthritis. On behalf of the OLR 302 Study Group.

Yocum DE, Allard S, Cohen SB, Emery P, Flipo RM, Goobar J, Jayawardena S, Job-Deslandre C, Jubb RW, Krüger K, Lopes Vaz A, Manger B, Mur E, Nygaard H, Weiner SM, Rainer F, Sack MR, Schiff MH, Schnitzer TJ, Trigg LB, Whatmough I, Schmidt AG. Yocum DE, et al. Among authors: emery p. Rheumatology (Oxford). 2000 Feb;39(2):156-64. doi: 10.1093/rheumatology/39.2.156. Rheumatology (Oxford). 2000. PMID: 10725065 Clinical Trial.

10

Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis.

Smolen JS, Breedveld FC, Burmester GR, Combe B, Emery P, Kalden JR, Klareskog L, Maini RN, Numo R, van De Putte LB, van Riel PL, Rodriguez-Valverde V. Smolen JS, et al. Among authors: emery p. Ann Rheum Dis. 2000 Jul;59(7):504-5. doi: 10.1136/ard.59.7.504. Ann Rheum Dis. 2000. PMID: 10873957 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,431 results

Search Page